Suggestions
Greg Gregory, PhD
Executive Vice President & Managing Director, Consulting | Market Access, Pricing, and Commercialization Strategist | Biopharmaceuticals, Orphan Drugs, & Vaccines
Dr. Greg Gregory, with a PhD in Immunology & Molecular Pathogenesis from Emory University and a BS in Microbiology from the University of Rochester, boasts over 40 years of experience in bioscience and biomedical research. His passion for bioscience led him to transition to consulting, focusing on rare diseases, orphan drug commercialization, and launching over 30 vaccines and passive immunization agents. Dr. Gregory is known for his strategic consulting expertise in pricing & contracting, market access, commercial development, and patient support services within the biopharmaceutical industry.
Highlights
Biopharma's "Next" Frontier: Enhancing Patient Access & Redefining the Value Chain?
As biopharma manufacturers increasingly focus on patient-centric models, we see potentially innovative strategies emerging to address critical gaps in patient access and care. Companies like Pfizer and Eli Lilly and Company are leading the charge with direct-to-consumer platforms, connecting patients more directly with their medications and telehealth resources. Moreover, Dexcom came to market yesterday with the first over-the-counter Continuous Glucose Monitor. These trends may not only improve patient outcomes but also represent strategic moves to streamline the value chain, potentially reducing the role of intermediaries. The future of healthcare is evolving—let’s keep our eyes on these developments. Want to learn more? Let Precision AQ help you explore your value chain.
#HealthcareInnovation #Biopharma #PatientAccess
I am so excited to share this news: The Precision Value & Health family of brands unite to become Precision AQ! This unification brings together the most comprehensive range of commercialization services, data and products in the industry – all with one goal – helping our clients get their life-changing medicines to the patients who need them. Our 1200 experts bring a holistic understanding of each individual and every unique need along the commercial continuum. Our distinct and collaborative approach fuses scientific rigor with the deepest human empathy.
Where IQ meets EQ, we are Precision AQ.
